Hudson Bay Capital Management LP

Position in NBIX — Neurocrine Biosciences Inc

CIK 1393825 STAMFORD, CT

Back to NBIX Full portfolio

Position in NBIX

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$52,149,278

+$8,891,128 QoQ

Shares Held

395,850

+29.8% QoQ

Ownership

0.394%

of shares outstanding

% of Portfolio

0.36%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

24 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Hudson Bay Capital Management LP holds $123,784,198 across 12 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (42.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc This page	395,850	$52,149,278
2	BHC	Bausch Health Companies Inc.	5,000,000	$27,000,000
3	UTHR	UNITED THERAPEUTICS Corp	20,918	$12,403,955
4	INDV	Indivior Pharmaceuticals, Inc.	364,212	$11,101,181
5	ALKS	Alkermes plc.	173,626	$6,139,415
6	SUPN	Supernus Pharmaceuticals, Inc.	90,821	$4,694,536
7	BCRX	Biocryst Pharmaceuticals Inc	490,369	$4,668,312
8	HIMS	Hims & Hers Health, Inc.	151,366	$3,142,358

All Filings in NBIX

Export CSV

24 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$52,149,278	395,850	+29.8%	Shares	Sole	2026-05-13
2025-12-31	$43,258,150	305,000	+652.9%	Shares	Sole	2026-02-13
2025-09-30	$5,686,793	40,510	-47.8%	Shares	Sole	2025-12-15
2025-06-30	$9,752,664	77,593	-48.4%	Shares	Sole	2025-08-18
2025-03-31	$16,632,028	150,380	+395.6%	Shares	Sole	2025-05-14
2024-12-31	$4,141,683	30,342	-24.1%	Shares	Sole	2025-02-14
2024-09-30	$4,608,800	40,000	-11.1%	Shares	Sole	2024-11-13
2024-06-30	$6,195,150	45,000	+50.0%	Shares	Sole	2024-08-14
2024-03-31	$4,137,600	30,000	-47.8%	Shares	Sole	2024-05-15
2023-12-31	$7,576,200	57,500	+15.0%	Shares	Sole	2024-02-14
2023-09-30	$5,625,000	50,000	-35.5%	Shares	Sole	2023-12-07
2023-06-30	$7,308,250	77,500	+158.3%	Shares	Sole	2023-08-14
2023-03-31	$3,036,600	30,000	+176.8%	Shares	Sole	2023-05-16
2022-12-31	$1,294,729	10,840	-89.7%	Shares	Sole	2023-02-14
2022-09-30	$11,152,050	105,000	-38.2%	Shares	Sole	2022-11-14
2022-06-30	$16,571,600	170,000	+9.7%	Shares	Sole	2022-08-12
2022-03-31	$14,531,250	155,000	+14.8%	Shares	Sole	2022-05-16
2021-12-31	$11,497,950	135,000	+69.0%	Shares	Sole	2022-02-14
2021-09-30	$7,662,153	79,889	+14.1%	Shares	Sole	2021-12-29
2021-06-30	$6,812,400	70,000	+7.7%	Shares	Sole	2021-08-16
2021-03-31	$6,321,250	65,000	-7.1%	Shares	Sole	2021-05-14
2020-12-31	$6,709,500	70,000	+133.3%	Shares	Sole	2021-03-04
2020-09-30	$2,884,800	30,000	+200.0%	Shares	Sole	2020-11-12
2020-03-31	$865,500	10,000	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.